Our New Must-Read Journal
Population Health, Equity & Outcomes is our newest journal featuring content on health equity, population health, and improved outcomes.
Latest News
View All
CNS-Directed AAV Gene Therapy: Immune Dynamics and Clinical Implications
Zanubrutinib Not Cost-Effective in China Against Fixed-Duration R-Bendamustine in 1L CLL
Data Show Undocumented Latinx People Face Disproportionate Burden of Long COVID
Protein Level Correlates With Pediatric SMA Severity, Treatment Response
Data Show Undocumented Latinx People Face Disproportionate Burden of Long COVID
Early Intervention, Targeted Strategies Needed to Improve Disparities, Survival in Patients With IPF
Misdiagnosis of Bipolar Disorder and the Impact on Patient Treatment
Access Has Improved for Diverse Patients Needing Umbilical Cord Blood Transplant, but Disparities Remain
CHEST 2024 Posters Reveal Disparities in Acute Coronary Syndrome Care, Outcomes
Community Engagement, Culturally Tailored Care as a Gateway to Advancing Health Equity
Dr Cesar Davila-Chapa Calls for Awareness of Racial Differences in IPF Hospitalization
The Opioid Epidemic Continues While Effective Medication Is Underutilized
Making Cancer Care Easier With Community Bispecific Antibody Programs
Financial Advocacy Should Start Before Patients Learn They Have Cancer, Says Dr Nadine Barrett
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Integrating HER2-Directed Therapies Into Standard Care for NSCLC
Impact of IPF on Quality of Life and Financial Considerations
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
ASCO 2024 and Beyond: Addressing NSCLC Unmet Needs and Future Research Directions
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Care Coordination for High-Risk CRM Patients
AMCP’s Adam Colborn Discusses Aspects of the IRA and Impact on Patients
Overview of Idiopathic Pulmonary Fibrosis (IPF)
Misdiagnosis of Bipolar Disorder and the Impact on Patient Treatment
Coverage Trends of Specialty Drugs Create Confusing Situations for Patients
The Day-to-Day Effect of a Schizophrenia Diagnosis on Patient Quality of Life
Diagnostic Challenges With Schizophrenia Delay Important Treatment
Early Intervention, Targeted Strategies Needed to Improve Disparities, Survival in Patients With IPF
AMCP’s Adam Colborn Discusses Aspects of the IRA and Impact on Patients
Strategies to Boost Biosimilar Adoption and Improve Patient Access
Navigating the “Really Exciting” Specialty Pharmaceutical Pipeline
The Daily Balancing Act of Value-Based Cancer Care
Transforming Value-Based Oncology Care in an Evolving Therapeutic Landscape
Putting a Spotlight on Innovation, Collaboration in Specialty Value-Based Care
Racial and Ethnic Disparities in Prior Authorizations for Patients With Cancer
Impact of Functional Recovery on Patients Having Heart Surgery
Patient Assignment and Quality Performance: A Misaligned System
Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Treatment Costs
Care Transition Management and Patient Outcomes in Hospitalized Medicare Beneficiaries
COPD Treatment Ratio: A Measure for Improving COPD Population Health
Healthy State: Practicing What They Preach in Louisiana
New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist
Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden
Managed Care Perspectives on the Burden of Food Allergies and Advances in Treatment
Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies
PARP Inhibitors for Ovarian Cancer: An Oncology Pharmacist's Guide to the Latest Clinical Advancements
Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care
Managed Care Pharmacy: A Plan for the Future and How Pharmacists Are Leading the Way
Navigating the Evolving Treatment Landscape of Metastatic Renal Cell Carcinoma
ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care
Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction
